Skip to main content
ASTEC LIFESCIENCES LIMITED logo

ASTEC LIFESCIENCES LIMITED — Investor Relations & Filings

Ticker · ASTEC ISIN · INE563J01010 LEI · 335800HR6FY1BUFVHG81 BSE.NS Manufacturing
Open in API
Filings indexed 859 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country IN India
Listing BSE.NS ASTEC

About ASTEC LIFESCIENCES LIMITED

https://www.godrejastec.com

Astec LifeSciences Limited, a subsidiary of Godrej Agrovet Limited, specializes in the manufacture of agrochemical active ingredients, intermediates, and multi-product pharmaceutical intermediates. The company focuses on the development and production of a wide range of fungicides, herbicides, and insecticides, with a particular expertise in triazole chemistry. Astec operates as a Contract Development and Manufacturing Organization (CDMO), providing customized synthesis and manufacturing solutions to global life sciences and crop protection companies. Its operations are supported by advanced research and development centers and large-scale manufacturing facilities capable of handling complex chemical processes. The company serves a diverse international clientele, exporting products to numerous countries while maintaining a significant presence in the domestic market through high-quality technical grade products and formulations.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 85% confidence The document is an official notice sent by Astec LifeSciences Ltd. to the stock exchanges and shareholders regarding the corporate action of transferring shares (with unclaimed dividends for 7 years) to the Investor Education and Protection Fund (IEPF) under Section 124(6) of the Companies Act. It does not contain financial statements, voting results, dividend amounts, or management analysis, nor is it an investor presentation or report publication announcement. This is a general regulatory announcement/corporate action notice required under listing regulations, which fits the fallback “Regulatory Filings” category.
2026-05-21 English
Please find enclosed copy of newspaper publication.
Regulatory Filings Classification · 85% confidence The document is a formal notice to shareholders and stock exchanges regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) due to unclaimed dividends for seven consecutive years. It is not announcing financial results, dividends, board changes, mergers, or issuing a report itself (e.g., annual or interim report). Rather, it is a regulatory compliance announcement under Companies Act provisions. There is no detailed financial data, call transcript, or presentation attached—just a compliance notice. Therefore, it best fits the catch-all “Regulatory Filings” category (RNS).
2026-05-21 English
General Updates
Regulatory Filings Classification · 78% confidence The document is a formal notice filed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to stock exchanges and shareholders regarding the transfer of equity shares to the Investor Education and Protection Fund for unclaimed dividends over seven years. It does not present financial results or an annual/interim report, nor is it an earnings release, board change, dividend declaration, or governance charter. It is a standard regulatory disclosure to satisfy continuous listing obligations, so it falls under the general “Regulatory Filings” category (RNS) as a fallback for miscellaneous compliance notices.
2026-05-20 English
Please find enclosed, notice to the Shareholders of the Company for transfer of Unclaimed Dividend and Equity Shares to Investor Education and Protection Fund (IEPF)
Regulatory Filings Classification · 85% confidence The document is a formal disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notifying stock exchanges and shareholders about the transfer of unclaimed dividends and corresponding equity shares to the Investor Education and Protection Fund (IEPF). It does not contain actual financial statements, constitute a report publication (RPA), nor announce a dividend payment schedule (DIV). It is a regulatory compliance announcement, which falls under the general Regulatory Filings category (RNS).
2026-05-20 English
General Updates
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the grant of stock options under the company's Employee Stock Option Plan (ESOP). It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and SEBI Share Based Employee Benefits Regulations, 2021. The content is about the approval and grant of stock options to an employee, detailing the number of options, exercise price, vesting period, and exercisability. This is a typical announcement related to share-based employee benefits and capital changes. It is not a financial report, earnings release, or management discussion. It is also not a report publication or certification. The closest fitting category is Share Issue/Capital Change (SHA), as it involves issuance of stock options which affect capital structure.
2026-04-30 English
Copy of Newspaper Publication
Annual Report Classification · 95% confidence The document is a detailed disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains an extract of the audited consolidated and standalone financial results for the quarter and financial year ended 31st March 2026. The results have been approved by the Board of Directors and audited by statutory auditors with an unmodified opinion. The document includes comprehensive financial data such as total income, net profit/loss, reserves, debt equity ratio, earnings per share, and other financial metrics for the specified periods. It also includes notes explaining the audit, rights issue, labor code impact, and other relevant financial disclosures. The length and detail of the document, along with the presence of audited financial statements and comprehensive financial analysis, indicate that this is a full financial report for the fiscal year. Therefore, this document fits the definition of an Annual Report (10-K) rather than a mere announcement or summary. The document is not a short announcement or a certification letter but a substantive financial report with audited results for the full fiscal year ending 31 March 2026.
2026-04-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.